Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Improving the multidisciplinary care and management of patients at risk of venous thromboembolism (VTE) NIHR Collaborations in Leadership in Applied Health.
The Thrombosis Committee: an Instrument for Governance & Change
VTE Assessments in Acute General Medicine at the John Radcliffe Hospital Srimathy Vijayan CMT 1, John Radcliffe Hospital Learning To Make a Difference.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Deep Vein Thrombosis (DVT)
Anne Blumgart Principal Pharmacist DUE Improvement Science Professional Development Program Venous Thromboembolism (VTE) Prevention in Ward 9.
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
QAH HospitalPortsmouth Hospitals NHS Trust Venous Thromboembolism Patient Safety Study Day Simon Freathy.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
The Health Roundtable 3-3c_HRT1215-Session_HANNAFORD_UNSW_NSW How many people received appropriate VTE prophylaxis? Presenter: Natalie Hannaford UNSW Innovation.
Development and Testing of a Risk Assessment Model for Venous Thrombosis in Medical Inpatients: The Medical Inpatients and Thrombosis (MITH) Study Score.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
CMS Core Measures Evidence-Based Performance Measurement.
 When untreated, general postsurgical patients risk for Deep Venous Thrombosis (DVT) is 19%-25% (Buckner, et al., 2013).  Post surgical orthopedic patients.
Venous ThromboEmbolism
Ferris State University Nursing Research Presented by: Rebecca Enright, Jiali Luc, Jenny Parish, Ashley Weststrate.
Venous Thromboembolism Safety Tool Kit Brenda K. Zierler, PhD, RN, RVT University of Washington Medication Safety: Tools for Diverse Settings September.
Addenbrooke’s Hospital Rosie Hospital Caring for Patients in their Last Days of Life Dr Douglas Maslin (ACF CMT1) and Dr Kate Kiln (CMT2) Supervisor: Dr.
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
Hospital acquired VTE Alert system Caroline Baglin Thrombophilia CNS.
Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy Helberg, BSN,RN, CPHQ.
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
A Regional Approach to Improvement Julie Branter Associate Director for Clinical Governance and Patient Safety 21 September 2010 South West Strategic Health.
Peter Davies Senior Pharmacist.  Venous thromboembolic prevention is a DH patient safety priority  NICE clinical guideline venous thromboembolism reducing.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Low-molecular-weight heparin (LMWH) use in an oncological setting Emma Lowe, Melanie Lowe, Hilary Oldham, Joan Karasu. Clinical service technicians, Pharmacy.
VTE Venous ThromboEmbolism. VTE – aims of this module To define the terms associated with VTE and offer maximum care to treat patients. To define the.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.
DVT Prevention and Anticoagulant Management
VTE prevention and anticoagulation practice VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis Nurse RCHT.
A Strategy for Auditing VTE Prevention Rebecca Brown Carol Law
Pregnancy care in women with BMI>35 Dr S Sharma, Dr A Mahmud and Dr N Manheri-OthayothUniversity Hospital of Wales, Cardiff UK Pregnancy care in women.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Risk Assessment for VTE. Which of the following best describes you?
Mandatory Training: VTE prevention and anticoagulation practice Mandatory Training: VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary Embolism 1 (RECORD 1 ) Journal Club General Surgery Rotation.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Developing a systems-based approach to VTE a UK perspective Dr Anita Thomas OBE, UK.
Orthopaedic Thromboprophylaxis: Experience from Derriford Hospital
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Fundamental Research in Oncology & Thrombosis FRONTLINE 1 Survey.
‘Preventing and treating blood clots’ The South Tees Anticoagulation Team 1.
JUST GIVE IT: a 2 phase study to audit the Immediate Management of Patients with Proven or Suspected Neutropenic Sepsis by Ally Gruber Acute Oncology Clinical.
Insert name of presentation on Master Slide Hospital Acquired Thrombosis Simon Noble and Mike Fealey.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Dr N Mudondo (FY2) Mr C Chatzdimitriou (SpR Breast Surgery) Mr M Haider (SpR Breast Surgery)
Anthony Williams, FY2 Jo McCarthy, FY2 Charlotte Davies, FY2
Venous Thromboembolism Prophylaxis (VTE)
Evaluating The Accuracy Of International Classification Of Diseases 10TH Revision Codes For Venous Thromboembolism (VTE) And Major Bleeding (MB) in.
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
APEX Trial design: Patients hospitalized with an acute medical illness were randomized to oral betrixaban for days (n = 3,759) versus subcutaneous.
Assessing the uptake of national initiatives
Deep vein thrombosis outpatient pathway and ultrasound sensitivity
Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon
Ortho Warfarin Dosing Protocol
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Coagulation Screening In Elective & Emergency General Surgery
OBMC Core Measures January 2015
Preventing VTE in hospitalised patients
GHS Outpatient Enoxaparin Program
Critical Care Outreach Medway
Cardiff and Vale UHB Dr Graham Shortland
Presentation transcript:

Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital VTE Audit Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital

What is VTE? Collective term for deep vein thrombosis and pulmonary embolism. DVT is common but causes symptoms in 1/1000 a year in general population. PE often results from asymptomatic DVT- can be fatal, or if not can delay discharge and increase morbidity. Resolved DVT can cause post thrombotic complications (ulcers, swelling etc)

Guidelines NICE guidelines recommend every patient admitted to be hospital should be assessed for VTE prophylaxis. Patients should be reassessed at 24hrs, if their condition changes and before discharge. NICE guidelines state that all patients on admission should be assessed for risk of VTE. The guidelines go on to state to start mechanical VTE prophylaxis at admission and add pharmacological prophylaxis for those who it is not contraindicated (e.g. low risk of major bleeding).

There is an existing VTE assessment protocol on the BCU intranet as part of the 1000lives programme (one for acute surgery shown)

Aims and standards Aims All patients should be assessed on admission to hospital to identify those who are at increased risk of venous thromboembolism (VTE) All patients should be assessed for risk of bleeding before offering pharmacological VTE prophylaxis The risks of bleeding and VTE should be reassessed within 24 hours of admission. Data Will assess drug charts for completion of requirement and prescription of VTE prophylaxis on all patients on Fleming, Lister and SAU wards Will include medical and surgical patients Will compare on call surgical patients to surgical and medical inpatients Will not include reviewing of patient notes

Data Data collected from Lister, SAU and Fleming wards Empty or unoccupied beds were those where the bed had been vacated or the patient had been taken to theatre at time of data collection. 11 On call 6 Medical 53 Inpatient

Results

Results Therefore standards currently not being met

Prophylaxis prescribed as a percentage?

TEDs prescription

Further Results 1 patient was written up for teds and enoxaparin, but it had not been signed. 1 patient had TEDS and enoxaparin written on the front of their chart, but only enoxaparin prescribed None of the warfarinised patients (3) had mechanical VTE prophylaxis prescribed.

Conclusions Currently standards not being met. Not all patients are having VTE assessments completed on the front of their charts. Not all pts are being prescribed VTE. Patients may not be adequately being re-assessed for VTE prophylaxis Many patients who could have mechanical prophylaxis are not having it. Some patients are being given TEDS without prescription which could potentially be hazardous.

Limitations Audit only performed on one day- there may be variation in on-call team prescriptions Not all NICE recommended VTE audit points were covered during this audit This audit did not differentiate between elective and emergency surgical admissions amongst the surgical inpatients. Medical notes were not consulted as to reasoning for no prophylaxis- therefore it is difficult to assess whether absence of prophylaxis appropriate in some cases.

Recommendations Continuing staff education as to importance of VTE prophylaxis VTE assessment tool as part of drugs charts or as part of a surgical admission booklet As of April 2016, there is going to be a revision of the All Wales Drug Chart which will have a VTE prophylaxis assessment as part of the chart It is therefore recommended that this topic be re-audited following the adoption of this chart.

References National Institute for Health and Clinical Excellence. Venous thromboembolism: reducing the risk. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE clinical guideline 92.London: NICE publications, 2010. https://www.nice.org.uk/guidance/cg92 http://howis.wales.nhs.uk/sitesplus/documents/861/acute_surgical_intera ctive1.pdf (Acute surgical admission form 1000 lives) http://webarchive.nationalarchives.gov.uk/20130107105354/http://www. dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/doc uments/digitalasset/dh_113355.pdf (DoH VTE assessment guideline)